Producing the highest accuracy, the 9-gene set produced became the basis of the final classifier. When applied to multiple ...

Clinicians and health system leaders met in Cleveland, Ohio, on October 23, 2025, to share improvements to value-based care ...

RAISE focuses on improving race and ethnicity data collection to address healthcare disparities and unmet medical needs. The ...

There were no fatal treatment-emergent adverse events (TEAEs) in either patient group, but exposure-adjusted incidence rates ...

The researchers argue that their findings, published in Scientific Reports, could help clinicians anticipate which patients ...

Despite clear NCCN guidelines for frontline chronic lymphocytic leukemia (CLL) therapies, significant racial and ethnic ...

Innovative deep proteomic profiling reveals promising results from a blood-based test for early breast cancer, showcasing ...

Overall, Contreras concluded that DM-BUP represents a promising advancement in Alzheimer care, offering a safer, effective, ...

Discover more about seasonal affective disorder in this interview with Craig Sawchuk, PhD, LP, clinical psychologist at Mayo ...

Overall, Contreras underscored that combining predictive analytics, AI-driven modeling, and digital monitoring can help ...

Kelonia Therapeutics' KLN-1010 has shown promising early results in a phase 1 trial for relapsed or refractory multiple ...

A new phase 2 clinical trial suggests that a chemotherapy-free, minimal residual disease (MRD)–driven treatment strategy may offer durable remissions and the possibility of time-limited therapy for ...